The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Clinical characteristics and outcomes for patients with thymic carcinoma: Evaluation of Masaoka staging.
Anna Maria Litvak
No relevant relationships to disclose
Kaitlin Woo
No relevant relationships to disclose
Sara A. Hayes
No relevant relationships to disclose
Camelia S. Sima
No relevant relationships to disclose
James Huang
No relevant relationships to disclose
Andre L. Moreira
No relevant relationships to disclose
Maria Teresa Ruiz Tsukazan
No relevant relationships to disclose
Gregory J. Riely
Consultant or Advisory Role - Abbott Laboratories; ARIAD; Celgene; Chugai Pharma; Daiichi Sankyo; Foundation Medicine; Novartis; Tragara Pharmaceuticals
Research Funding - Chugai Pharma; GlaxoSmithKline; Infinity Pharmaceuticals; Merck; Millennium; Novartis; Pfizer